Robert E. Emerson

Robert E. Emerson

Auto-generated profile, based on publicly available information

Robert E. Emerson

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
OKOlga Kim
Olga Kim
EPEun Young Park
Eun Young Park
SKSun Young Kwon
Sun Young Kwon
SSSojin Shin
Sojin Shin
RERobert E. Emerson
Robert E. Emerson
JKJaeyeon Kim
Jaeyeon Kim
Significance: Why women carrying a pathogenic germlineBRCA1mutation are predisposed to ovarian and breast cancer remains elusive. This study points to ovarian progesterone as a culprit. Generally,BRCA1-mutation carriers exhibit high yet individually varying levels of progesterone during the menstrual cycle. Although not allBRCA1-mutation carriers develop these cancers, all of them are advised to undergo prophylactic surgeries at a young age (under 40 y to 45 y) to prevent ovarian and breast cancer. Insights from robust in vivo findings in this study offer a novel concept: Targeting progesterone signaling with antiprogestins could be an effective nonsurgical prophylactic option for ovarian and breast cancer prevention for these high-risk women.